Found 23 articles for: "Carcinoma"
Multidisciplinary Approach to Treatment of Advanced Basal Cell Carcinoma With Involvement of the Left Orbit
June 2024 | Volume 23 | Issue 6 | Case Reports | e142 | Copyright © June 2024
Incorporating a Prognostic Gene Expression Profile Test into the Management of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel Report
February 2024 | Volume 23 | Issue 2 | Original Article | 54 | Copyright © February 2024
Background: Cutaneous squamous cell carcinoma (cSCC) is a growing health concern with a rapidly increasing incidence. Disease-specific mortality is typically preceded by a m...
Read MoreCryosurgery and 5-Fluorouracil Combination Therapy for Treatment of Bowen's Disease and Superficial Basal Cell Carcinoma
December 2023 | Volume 22 | Issue 12 | Original Article | 1166 | Copyright © December 2023
Background: Non-melanoma skin cancer (NMSC), which includes both Bowen's disease (BD) and superficial basal cell carcinoma (sBCC), is the most commonly diagnosed cancer in Canada...
Read MoreKeratinocyte Carcinoma Chemoprevention With a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin
May 2023 | Volume 22 | Issue 5 | Original Article | 486 | Copyright © May 2023
Background: The incidence of keratinocyte carcinomas (KCs), comprising basal and squamous cell carcinomas, is rising in the United States. Chemoprevention is one modality by whic...
Read MoreNon-Invasive Treatment of Basal Cell Carcinoma: Photodynamic Therapy Following Curettage
May 2023 | Volume 22 | Issue 5 | Original Article | 481 | Copyright © May 2023
Background: To investigate the effectiveness, safety, patient satisfaction, and cosmetic outcome of Methyl Aminolevulinate-Photodynamic Therapy (MAL-PDT) following curettage in o...
Read MoreEruptive Squamous Cell Carcinomas Following Treatment With Fludarabine and Discussion of Treatment
May 2023 | Volume 22 | Issue 5 | Case Reports | 509 | Copyright © May 2023
Shah M, Wald J, Hanke CW. Eruptive Squamous cell carcinomas following treatment with fludarabine and discussion of treatment. J Drugs Dermatol. 2023;22(5):509-510....
Read MoreDilute Intralesional 5-Fluorouracil for the Treatment of Squamous Cell Carcinomas and Keratoacanthomas: A Case Series
May 2023 | Volume 22 | Issue 5 | Case Reports | 507 | Copyright © May 2023
Background: Intralesional 5-fluorouracil (5-FU) is a promising, yet sparsely studied alternative to surgical treatment for nonmelanoma skin cancer (NMSC).1 Previous studies of in...
Read MoreNon-Invasive Diagnosis of Sun Damaged Skin: Actinic Keratosis Vs Squamous Cell Carcinoma
May 2023 | Volume 22 | Issue 5 | Original Article | 440 | Copyright © May 2023
Importance: Actinic keratosis (AK) is a premalignant lesion that has a1% to 10% potential of progression to squamous cell carcinoma (SCC), but it is not possible to determine whi...
Read MorePigmented Basal Cell Carcinoma: An Argument for Sub-Classification
February 2023 | Volume 22 | Issue 2 | Features | 217 | Copyright © February 2023
Basal cell carcinoma (BCC) has several subclassifications, including pigmented basal cell carcinoma. In our clinical experience, we have found that pigmented basal cell carcinoma itself has multiple s...
Read MoreTreatment of Reactive Keratoacanthomas with Acitretin Following Multiple Excisions and Mohs Surgery for Recurrent Squamous Cell Carcinoma
December 2022 | Volume 21 | Issue 12 | Case Reports | 1353 | Copyright © December 2022
Surgical intervention is seen as the gold standard in the treatment of Squamous cell carcinoma. Yet, in cases of recurrence, repeated surgical procedures may unwittingly foment the rise of reactive ke...
Read MoreA Narrative Review of Nicotinamide Adenine Dinucleotide (NAD)+ Intermediates Nicotinamide Riboside and Nicotinamide Mononucleotide for Keratinocyte Carcinoma Risk Reduction
October 2022 | Volume 21 | Issue 10 | | 1129 | Copyright © October 2022
Oral nicotinamide (NAM) supplementation has been shown to decrease the incidence of keratinocyte carcinoma (KC) in high-risk skin cancer patients. NAM is a nicotinamide adenine dinucleotide (NAD+) int...
Read MoreKeratinocyte Carcinomas in Immunocompromised Patients Are Reduced After Administration of the Nonavalent Human Papillomavirus Vaccine
May 2022 | Volume 21 | Issue 5 | | 526 | Copyright © May 2022
Immunosuppression, as seen in solid organ transplant recipients, is highly associated with the development of keratinocyte carcinomas (KCs). Reducing the level of immunosuppression lowers the incidenc...
Read MoreSafety and Efficacy of TGF-β1/COX-2 Silencing Therapeutic in Adults With Cutaneous Squamous Cell Carcinoma In Situ
May 2022 | Volume 21 | Issue 5 | Original Article | 472 | Copyright © May 2022
This single-center, open label, dose escalation cohort study evaluated the safety and efficacy of various doses of intralesional injections of TGF-Read More
Antidiabetic Treatment in Patients at High Risk for a Subsequent Keratinocyte Carcinoma
May 2022 | Volume 21 | Issue 5 | Original Article | 502 | Copyright © May 2022
Background: Metformin and sulfonylureas are the most commonly prescribed drugs used for the treatment of type II diabetes. Type II diabetes has been linked to the development of kerat...
Read MoreGiant Basal Cell Carcinoma of the Axilla: 8-year Follow-up of a Case Treated with Excision, Vismodegib, and Radiotherapy
May 2022 | Volume 21 | Issue 5 | Case Reports | 531 | Copyright © May 2022
Axillary giant basal cell carcinoma is extremely rare and remains challenging for physicians. The few reported cases have a relatively short-term follow-up, and none were treated with an oral hedgehog...
Read MoreDermoscopy and Reflectance Confocal Microscopy in Actinic Keratosis, Intraepithelial Carcinoma, and Invasive Squamous Cell Carcinoma
March 2022 | Volume 21 | Issue 3 | Original Article | 259 | Copyright © March 2022
Background: Patients with multiple actinic keratosis (AK), have pre-neosplastic abnormalities, constituting the sites of new tumors, this region is called the cancerization field. Due...
Read MoreExtrafacial Merkel Cell Carcinoma Presenting as a Cyst
March 2022 | Volume 21 | Issue 3 | Original Article | 304 | Copyright © March 2022
Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine skin tumor that presents as an erythematous or violaceous nodule in elderly white males with an extensive history of sun exposure. Here...
Read MoreCharacteristics of Superficial Basal Cell Carcinomas Containing More Aggressive Subtypes on Final Histopathologic Diagnosis
August 2021 | Volume 20 | Issue 8 | Original Article | 874 | Copyright © August 2021
Background: The prognosis and treatment of basal cell carcinoma (BCC) are largely dependent on tumor subtype, which is typically determined by punch or shave biopsy. Data regarding co...
Read MoreCombining Panitumumab With Anti-PD-1 Antibody in Cutaneous Squamous Cell Carcinoma of the Head and Neck After Inadequate Response to Anti-PD-1 Antibody Alone
August 2021 | Volume 20 | Issue 8 | Case Reports | 901 | Copyright © August 2021
Anti-epidermal growth factor receptor (EGFR) antibodies and anti-programmed cell death 1 protein (PD-1) antibodies have been used separately to treat metastatic cutaneous squamous cell carcinoma (cSCC...
Read MoreBasal Cell Carcinoma Gene Mutations Differ Between Asian, Hispanic, and Caucasian Patients: A Pilot Study
May 2021 | Volume 20 | Issue 5 | Original Article | 504 | Copyright © May 2021
Background: Basal cell carcinoma (BCC) is the most common malignancy worldwide. While most BCCs are treated surgically, adv...
Read More
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
